Perrigo Announces the Launch of Guaifenesin Extended-Release 600mg Tablets

Perrigo Company PRGO announced that it has initiated shipments of its Guaifenesin Extended-Release Tablets, 600mg (a generic version of Mucinex® 600mg tablets) product. This launch consists of product packaged in bottles to a number of customers. The company expects to initiate its full-scale over-the-counter (OTC) launch of product in blister packaging to its retail and wholesale customers in store brand or own label before the end of its current fiscal year.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!